AU2014306959B2 - Methods for increasing forced expiratory volume in asthmatics using benralizumab - Google Patents
Methods for increasing forced expiratory volume in asthmatics using benralizumab Download PDFInfo
- Publication number
- AU2014306959B2 AU2014306959B2 AU2014306959A AU2014306959A AU2014306959B2 AU 2014306959 B2 AU2014306959 B2 AU 2014306959B2 AU 2014306959 A AU2014306959 A AU 2014306959A AU 2014306959 A AU2014306959 A AU 2014306959A AU 2014306959 B2 AU2014306959 B2 AU 2014306959B2
- Authority
- AU
- Australia
- Prior art keywords
- methods
- benralizumab
- asthmatics
- expiratory volume
- forced expiratory
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
- C07K16/2866—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants against receptors for cytokines, lymphokines, interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/505—Medicinal preparations containing antigens or antibodies comprising antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/20—Immunoglobulins specific features characterized by taxonomic origin
- C07K2317/24—Immunoglobulins specific features characterized by taxonomic origin containing regions, domains or residues from different species, e.g. chimeric, humanized or veneered
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Immunology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicinal Preparation (AREA)
- Endocrinology (AREA)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2020201277A AU2020201277A1 (en) | 2013-08-12 | 2020-02-21 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201361864948P | 2013-08-12 | 2013-08-12 | |
US61/864,948 | 2013-08-12 | ||
PCT/US2014/050119 WO2015023507A2 (en) | 2013-08-12 | 2014-08-07 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020201277A Division AU2020201277A1 (en) | 2013-08-12 | 2020-02-21 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Publications (2)
Publication Number | Publication Date |
---|---|
AU2014306959A1 AU2014306959A1 (en) | 2016-02-04 |
AU2014306959B2 true AU2014306959B2 (en) | 2019-11-21 |
Family
ID=52448838
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2014306959A Active AU2014306959B2 (en) | 2013-08-12 | 2014-08-07 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
AU2020201277A Abandoned AU2020201277A1 (en) | 2013-08-12 | 2020-02-21 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU2020201277A Abandoned AU2020201277A1 (en) | 2013-08-12 | 2020-02-21 | Methods for increasing forced expiratory volume in asthmatics using benralizumab |
Country Status (25)
Country | Link |
---|---|
US (1) | US9441046B2 (zh) |
EP (3) | EP3875487A1 (zh) |
JP (3) | JP6746496B2 (zh) |
KR (1) | KR102337599B1 (zh) |
CN (2) | CN105451769A (zh) |
AU (2) | AU2014306959B2 (zh) |
BR (1) | BR112016002317A8 (zh) |
CA (1) | CA2917603C (zh) |
CY (2) | CY1122033T1 (zh) |
DK (2) | DK3520811T3 (zh) |
ES (2) | ES2733602T3 (zh) |
HK (2) | HK1222559A1 (zh) |
HR (2) | HRP20190920T1 (zh) |
HU (2) | HUE043497T2 (zh) |
LT (2) | LT3520811T (zh) |
ME (1) | ME03403B (zh) |
MX (2) | MX2016001384A (zh) |
PL (2) | PL3033104T3 (zh) |
PT (2) | PT3520811T (zh) |
RS (2) | RS58711B1 (zh) |
RU (1) | RU2703568C2 (zh) |
SG (1) | SG11201600483QA (zh) |
SI (2) | SI3033104T1 (zh) |
TR (1) | TR201907907T4 (zh) |
WO (1) | WO2015023507A2 (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2014306956B2 (en) | 2013-08-12 | 2019-11-21 | Astrazeneca Ab | Methods for reducing exacerbation rates of asthma using benralizumab |
KR102337601B1 (ko) * | 2013-08-12 | 2021-12-10 | 아스트라제네카 아베 | 벤랄리주맙을 이용하여 천식 증상을 개선시키는 방법 |
US20150104447A1 (en) * | 2013-10-15 | 2015-04-16 | Medimmune, Llc | Methods for treating chronic obstructive pulmonary disease using benralizumab |
SI3060229T1 (sl) * | 2013-10-24 | 2021-11-30 | Astrazeneca Ab | Stabilne vodne formulacije protiteles |
TW202110479A (zh) * | 2019-05-16 | 2021-03-16 | 瑞典商阿斯特捷利康公司 | 使用貝那利珠單抗治療增強型患者群體慢性阻塞性肺病之方法 |
TW202214692A (zh) * | 2020-06-05 | 2022-04-16 | 瑞典商阿斯特捷利康公司 | 治療患有鼻瘜肉的患者的重度氣喘之方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013066780A2 (en) * | 2011-11-01 | 2013-05-10 | Medimmune, Llc | Methods for reducing the frequency and severity of acute exacerbations of asthma |
Family Cites Families (16)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2233974T3 (es) | 1995-09-11 | 2005-06-16 | Kyowa Hakko Kogyo Co., Ltd. | Anticuerpo contra la cadena alfa del receptor de la interleucina 5 humana. |
US6746839B1 (en) * | 1998-01-12 | 2004-06-08 | Interleukin Genetics, Inc. | Diagnostics and therapeutics for an obstructive airway disease |
ES2571230T3 (es) | 1999-04-09 | 2016-05-24 | Kyowa Hakko Kirin Co Ltd | Procedimiento para controlar la actividad de una molécula inmunofuncional |
EP1266663A4 (en) | 2000-02-15 | 2003-07-23 | Kyowa Hakko Kogyo Kk | EOSINOPHILE SPECIFIC APOPTOSE INDUCTORS |
US6946292B2 (en) | 2000-10-06 | 2005-09-20 | Kyowa Hakko Kogyo Co., Ltd. | Cells producing antibody compositions with increased antibody dependent cytotoxic activity |
US8093357B2 (en) | 2002-03-01 | 2012-01-10 | Xencor, Inc. | Optimized Fc variants and methods for their generation |
WO2005035583A1 (ja) | 2003-10-08 | 2005-04-21 | Kyowa Hakko Kogyo Co., Ltd. | Il-5受容体に特異的に結合する抗体組成物 |
US20060014680A1 (en) | 2004-07-13 | 2006-01-19 | Caiding Xu | Peptides and compounds that bind to the IL-5 receptor |
WO2007041635A2 (en) | 2005-10-03 | 2007-04-12 | Xencor, Inc. | Fc variants with optimized fc receptor binding properties |
JP2010527356A (ja) * | 2007-05-14 | 2010-08-12 | メディミューン,エルエルシー | 好酸球レベルを低下させる方法 |
RU2383345C1 (ru) * | 2008-08-07 | 2010-03-10 | Государственное образовательное учреждение высшего профессионального образования "Нижегородская государственная медицинская академия Росздрава" (ГОУ ВПО "НИЖГМА РОСЗДРАВА") | Способ лечения больных бронхиальной астмой |
EP3447491A3 (en) * | 2010-12-16 | 2019-06-05 | F. Hoffmann-La Roche AG | Diagnosis and treatments relating to th2 inhibition |
CN102544908B (zh) | 2010-12-17 | 2016-01-06 | 富士康(昆山)电脑接插件有限公司 | 电连接器组件及插头连接器 |
WO2012158954A1 (en) * | 2011-05-18 | 2012-11-22 | Medimmune, Llc | Methods of diagnosing and treating pulmonary diseases or disorders |
AU2014306956B2 (en) * | 2013-08-12 | 2019-11-21 | Astrazeneca Ab | Methods for reducing exacerbation rates of asthma using benralizumab |
KR102337601B1 (ko) * | 2013-08-12 | 2021-12-10 | 아스트라제네카 아베 | 벤랄리주맙을 이용하여 천식 증상을 개선시키는 방법 |
-
2014
- 2014-08-07 EP EP20208316.8A patent/EP3875487A1/en active Pending
- 2014-08-07 PT PT191584465T patent/PT3520811T/pt unknown
- 2014-08-07 PT PT14836725T patent/PT3033104T/pt unknown
- 2014-08-07 HU HUE14836725A patent/HUE043497T2/hu unknown
- 2014-08-07 PL PL14836725T patent/PL3033104T3/pl unknown
- 2014-08-07 BR BR112016002317A patent/BR112016002317A8/pt not_active Application Discontinuation
- 2014-08-07 MX MX2016001384A patent/MX2016001384A/es unknown
- 2014-08-07 EP EP14836725.3A patent/EP3033104B1/en active Active
- 2014-08-07 ES ES14836725T patent/ES2733602T3/es active Active
- 2014-08-07 CN CN201480045047.8A patent/CN105451769A/zh active Pending
- 2014-08-07 SG SG11201600483QA patent/SG11201600483QA/en unknown
- 2014-08-07 RS RS20190556A patent/RS58711B1/sr unknown
- 2014-08-07 LT LTEP19158446.5T patent/LT3520811T/lt unknown
- 2014-08-07 SI SI201431191T patent/SI3033104T1/sl unknown
- 2014-08-07 ME MEP-2019-137A patent/ME03403B/me unknown
- 2014-08-07 RS RS20210305A patent/RS61565B1/sr unknown
- 2014-08-07 DK DK19158446.5T patent/DK3520811T3/da active
- 2014-08-07 RU RU2016108809A patent/RU2703568C2/ru active
- 2014-08-07 AU AU2014306959A patent/AU2014306959B2/en active Active
- 2014-08-07 DK DK14836725.3T patent/DK3033104T3/da active
- 2014-08-07 ES ES19158446T patent/ES2866426T3/es active Active
- 2014-08-07 TR TR2019/07907T patent/TR201907907T4/tr unknown
- 2014-08-07 HU HUE19158446A patent/HUE053627T2/hu unknown
- 2014-08-07 KR KR1020167006576A patent/KR102337599B1/ko active IP Right Grant
- 2014-08-07 PL PL19158446T patent/PL3520811T3/pl unknown
- 2014-08-07 US US14/454,138 patent/US9441046B2/en active Active
- 2014-08-07 JP JP2016534615A patent/JP6746496B2/ja active Active
- 2014-08-07 CA CA2917603A patent/CA2917603C/en active Active
- 2014-08-07 WO PCT/US2014/050119 patent/WO2015023507A2/en active Application Filing
- 2014-08-07 LT LTEP14836725.3T patent/LT3033104T/lt unknown
- 2014-08-07 EP EP19158446.5A patent/EP3520811B1/en active Active
- 2014-08-07 CN CN202010450690.6A patent/CN111588849A/zh active Pending
- 2014-08-07 SI SI201431795T patent/SI3520811T1/sl unknown
-
2016
- 2016-01-29 MX MX2021003826A patent/MX2021003826A/es unknown
- 2016-09-12 HK HK16110776.1A patent/HK1222559A1/zh unknown
- 2016-12-01 HK HK16113676A patent/HK1225300A1/zh unknown
-
2019
- 2019-05-17 HR HRP20190920TT patent/HRP20190920T1/hr unknown
- 2019-07-03 CY CY20191100700T patent/CY1122033T1/el unknown
-
2020
- 2020-02-21 AU AU2020201277A patent/AU2020201277A1/en not_active Abandoned
- 2020-04-03 JP JP2020067766A patent/JP2020125304A/ja not_active Withdrawn
-
2021
- 2021-03-10 HR HRP20210406TT patent/HRP20210406T1/hr unknown
- 2021-03-24 CY CY20211100261T patent/CY1124399T1/el unknown
-
2022
- 2022-06-07 JP JP2022092222A patent/JP2022120010A/ja active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2013066780A2 (en) * | 2011-11-01 | 2013-05-10 | Medimmune, Llc | Methods for reducing the frequency and severity of acute exacerbations of asthma |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3730615A3 (en) | Methods and compositions for treatment of a genetic condition | |
EP3061326A4 (en) | Hybrid generators and methods of using them | |
MX2015017103A (es) | Celulas beta derivadas de células madre ( sc-beta ) y composiciones y métodos para generarlas. | |
IN2014DN03472A (zh) | ||
EP3065875A4 (en) | Bioprinter and methods of using same | |
AU2014306959B2 (en) | Methods for increasing forced expiratory volume in asthmatics using benralizumab | |
UY4167Q (es) | Par de auriculares | |
TWD166111S (zh) | 速克達摩托車 | |
TWD171869S (zh) | 速克達摩托車 | |
EP2992528A4 (en) | Hybrid encoding of multichannel audio | |
EP3035521A4 (en) | Power generating apparatus | |
EP3014628B8 (en) | Process of generating germanium-68 | |
MY168394A (en) | Apparatus and Method of Using the Same | |
BR112014027219A2 (pt) | método | |
MY167584A (en) | Method for producing ethanol | |
AU2014205587A8 (en) | SHIP1 modulators and methods related thereto | |
WO2014146111A3 (en) | Analgesic compounds and methods of use | |
EP3003325A4 (en) | Methods of evaluating cell culture additives | |
EP3066261A4 (en) | Creping adhesives and methods for making and using same | |
MY167578A (en) | Novel cheese and method for producing the same | |
EP3052583A4 (en) | Flame-retardant formulations and methods relating thereto | |
AU2012208061A8 (en) | Instrument for producing kakiage and method for producing kakiage | |
TWD178255S (zh) | 齒間刷 | |
TWD167472S (zh) | 儀表面板 | |
TWD169940S (zh) | 速克達摩托車 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PC1 | Assignment before grant (sect. 113) |
Owner name: ASTRAZENECA AB Free format text: FORMER APPLICANT(S): MEDIMMUNE, LLC |
|
FGA | Letters patent sealed or granted (standard patent) |